Atrophic Vaginitis Treatment Market Is Anticipated To Witness High Growth Owing To Rising Prevalence Of Menopause

Atrophic Vaginitis Treatment Market

Atrophic vaginitis is a condition caused due to decreased levels of estrogen in women during and after menopause. Symptoms of atrophic vaginitis include dryness, burning sensation, itching and sometimes pain during sexual intercourse. Treatment of atrophic vaginitis includes use of lubricants, moisturizers and low-dose vaginal estrogen therapy. Vaginal estrogen therapy is the most effective treatment method which is usually prescribed in the form of creams, tablets or rings. The global atrophic vaginitis treatment market is estimated to be valued at US$ 758.4 Bn in 2024 and is expected to exhibit a CAGR of 6.1% over the forecast period 2024 to 2030.


Key Takeaways

Key players operating in the atrophic vaginitis treatment market are United Company RUSAL Plc, Alcoa Inc., Aluminum Corp. of China Ltd., Kaiser Aluminum Corporation, Norsk Hydro ASA, Dubai Aluminum Co., Constellium, Kobe Steel, Ltd., and Aluminum Bahrain B.S.C. These players are focused on developing new products and adopting inorganic growth strategies like collaborations and partnerships to expand their market share.

The increasing global geriatric population suffering from menopause and hormonal imbalance is expected to create numerous growth opportunities in the market. Companies are investing heavily in R&D to develop new drug formulations and treatment methods to capitalize on this opportunity.

The global leaders are expanding their operations in emerging markets of Asia Pacific and Latin America through strategies like joint ventures and acquisitions. The low manufacturing costs and growing healthcare investments in these regions are attracting large investments.

Market Drivers

Rising Prevalence of Menopause: The increasing prevalence of menopause worldwide due to rapidly growing elderly population base is a major factor boosting market growth. It is estimated that over 1 billion women worldwide will be in menopause by 2025.

Growing Awareness: Rising awareness about treatment options and available therapies for atrophic vaginitis is encouraging more women to seek medical help, driving market revenues.

Market Restraints

Side Effects of Estrogen Therapies: Though estrogen-based therapies are very effective, they may cause side effects like breast pain, menstrual irregularities, nausea etc. in some women which limits their uptake.

Lack of Treatment Options: There exist only a few approved therapies for atrophic vaginitis and unmet needs persist regarding alternate new treatment modalities which challenges market potential.

Segment Analysis
The Atrophic Vaginitis Treatment Market Scope is segmented based on type, treatment, distribution channel, and region. In terms of type, the market is divided into mild, moderate, and severe atrophic vaginitis. The moderate segment holds the largest market share owing to increasing prevalence of menopause that leads to moderate symptoms of atrophic vaginitis in women. Treatment-wise, the market is classified into estrogen therapy, estrogen-antimuscarinic therapy, and other therapies. Within these, estrogen therapy accounts for the dominant share as it is considered as the standard treatment recommended for women suffering from atrophic vaginitis.

Global Analysis
Regionally, North America commands the major share in the atrophic vaginitis treatment market due to growing female geriatric population experiencing menopause and related vaginal health issues. Also, higher per capita income enables better access to quality treatment in the region. On the other hand, Asia Pacific is pegged to witness the highest growth during the forecast period. This is attributed to improving healthcare infrastructure, increase in healthcare expenditures, rising awareness about women's health issues, and gradual adoption of latest treatment options. Japan, China, and India emerge as highly lucrative Asian markets.

Get More Insights On Atrophic Vaginitis Treatment Market

Comments

Post a Comment

Popular posts from this blog

The Global Hydrogen Aircraft Market Is Propel By Hydrogen Fuel Powers Eco-Friendly Aviation

Image
Hydrogen Aircraft Market  Hydrogen fuel cells provide onboard electricity with only water as a byproduct, making them an eco-friendly alternative to conventional jet fuels. Hydrogen fuel cells can power aircraft auxiliary systems and offer a range of over 1,000 nautical miles. The global hydrogen aircraft market is estimated to be valued at  US$ 7.76 Mn in 2023  and is expected to exhibit a  CAGR of 5.0%  over the forecast period 2023-2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: Green Flight Plans Drive Adoption of Hydrogen Technology Major airlines and aircraft manufacturers have announced plans to introduce hydrogen-powered commercial aircraft by 2035 as part of their commitments to achieving net-zero carbon emissions by 2050. The development of hydrogen fuel cell and storage systems suitable for aviation is being pursued through collaborative research programs. Government incentives and potential carbon credit...
Read more

Tissue Paper Market Growth Accelerated By Increasing Demand From Healthcare Facilities

Image
Tissue Paper Market Tissue paper is a lightweight paper which is used for various hygiene and sanitation purposes including toilet paper, facial tissues, paper towels, and napkins. Tissue paper provides softness, strength and absorbency, making it ideal for applications related to healthcare sector such as hospitals, nursing homes, and clinics. The increasing focus on hygiene and sanitation in healthcare facilities is anticipated to propel the demand for tissue paper products over the forecast period. The global Tissue Paper Market is estimated to be valued at   US$ 84.37 Bn   in   2023  and is expected to exhibit a   CAGR of 6.2%   over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing demand from healthcare sector is one of the major trends boosting the growth of the tissue paper market. With growing healthcare infrastructure and rising spending on healthcare services,...
Read more

Epstein - Barr Virus (EBV) vaccination is fastest growing segment fueling the growth of monovaccine market

Image
Monovaccines  Monovaccines refers to vaccines that provide protection against a single pathogen or disease. EBV monovaccine helps in preventing infectious mononucleosis caused by the Epstein–Barr virus. It offers advantages like conferring lifelong immunity, protection from various cancers associated with EBV infection and reducing disease burden in resource limited countries. The global monovaccine market is estimated to be valued at US$ 10.42 Bn in 2023 and is expected to exhibit a CAGR of 5.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the major trends in the monovaccine market is rising investment by manufacturers in research and development of EBV vaccines. As per statistics, around 95% of adult population gets infected by EBV at some point in their life making it an attractive target pathogen for vaccination development. Further, increasing awareness about EBV linked cancers lik...
Read more